Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 1Depression 1

Interventions

pegfilgrastim 1enzalutamide 1darolutamide 1apalutamide 1Therapeutics 1Surveys and Questionnaires 1Self Care 1Palliative Care 1Granulocyte Colony-Stimulating Factor 1Forest Therapy 1Filgrastim 1Educational Status 1Duloxetine Hydrochloride 1Cognitive Restructuring 1Analgesics 1Abiraterone Acetate 14-amino-4'-hydroxylaminodiphenylsulfone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Depression × Duloxetine Hydrochloride × Clear all
NCT02443194 2015-12-03

The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

Tel-Aviv Sourasky Medical Center

Phase 3 Terminated
50 enrolled
CNS

Depression, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡